Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-CO1 pseudogene 31 (MTCO1P31) is a human pseudogene, meaning it is a genomic DNA sequence similar to the functional mitochondrial cytochrome c oxidase I (MT-CO1) gene, but it is not expressed as a functional protein due to accumulated disabling mutations or lack of regulatory elements[5]. There are multiple pseudogenes for MT-CO1 listed in genomic databases, which are generally regarded as non-functional genomic "fossils" and are not considered therapeutic targets, receptors, enzymes, or transporters. MTCO1P31 specifically denotes the 31st annotated pseudogene of the MT-CO1 family in the human genome and has neither a demonstrated biological role nor clinical relevance for therapeutic intervention[4][5]. MT-CO1 (not the pseudogene) encodes the catalytic core of the mitochondrial cytochrome c oxidase complex, which is essential for electron transport and ATP production[1][3]. However, the pseudogene variant (MTCO1P31) does not share this function, is not biologically active, and should not be confused with the functional mitochondrial enzyme[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-CO1 pseudogene 31 (MTCO1P31).